Bristol Myers Squibb (CELG-RI) Restructuring Costs (2009 - 2013)

Bristol Myers Squibb (CELG-RI) has 5 years of Restructuring Costs data on file, last reported at $33.0 million in Q1 2013.

• Restructuring Costs for Q1 2013 came in at $33.0 million, up 50.0% year-over-year; the trailing twelve-month figure through Mar 2013 was $164.0 million (up 137.68% YoY), and the FY2012 annual result was $174.0 million, up 50.0% from the prior year.
• Restructuring Costs slipped to $33.0 million in Q1 2013 per CELG-RI's latest filing, from $103.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $103.0 million in Q4 2012 and troughed at $1.0 million in Q1 2011.
• A 5-year average of $27.9 million and a median of $20.0 million in 2012 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2011 and 2012: Restructuring Costs tumbled 90.91% in 2011, then surged 2100.0% in 2012.
• A 5-year view of Restructuring Costs shows it stood at $35.0 million in 2009, then surged by 80.0% to $63.0 million in 2010, then tumbled by 61.9% to $24.0 million in 2011, then jumped by 329.17% to $103.0 million in 2012, then tumbled by 67.96% to $33.0 million in 2013.
• Business Quant data shows CELG-RI's Restructuring Costs at $33.0 million in Q1 2013, $103.0 million in Q4 2012, and $8.0 million in Q3 2012.